Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J E Hay

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
The American Journal of Gastroenterology|August 1, 1993
Prevalence of peritonitis and the ascitic fluid protein concentration among chronic liver disease patientsD B Hurwich, K D Lindor, J E Hay, et al.
Hepatology (Baltimore, Md.)|August 1, 1991
The metabolic bone disease of primary sclerosing cholangitisJ E Hay, K D Lindor, R H Wiesner, et al.
Journal of Clinical Microbiology|January 1, 1996
Clinical comparison of isolator, Septi-Chek, nonvented tryptic soy broth, and direct agar plating combined with thioglycolate broth for diagnosing spontaneous bacterial peritonitisJ E Hay, F R Cockerill, D Kaese, et al.
Transplantation Proceedings|February 1, 1991
Bone disease in liver transplant recipients: incidence, timing, and risk factorsM K Porayko, R H Wiesner, J E Hay, et al.
Transplantation|November 15, 1994
Treatment of early cellular rejection following liver transplantation with intravenous methylprednisolone. The effect of dose on responseR H Wiesner, J Ludwig, R A Krom, et al.
The American Journal of Gastroenterology|September 1, 1994
Etiology and incidence of unconjugated hyperbilirubinemia after orthotopic liver transplantationL K Gates, R H Wiesner, R A Krom, et al.
Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 1, 1996
Liver transplantation for primary sclerosing cholangitis: impact of risk factors on outcomeR H Wiesner, M K Porayko, J E Hay, et al.
Transplantation Proceedings|April 1, 1993
Early cellular rejection treated with high-dose intravenous corticosteroid therapy is associated with a decrease in the incidence of steroid-resistant rejection and graft failure from rejectionR H Wiesner, M K Porayko, H E Wahlstrom, et al.
Transplantation Proceedings|June 1, 1996
Bone loss after orthotopic liver transplantation: FK 506 versus cyclosporineK M Park, J E Hay, S G Lee, et al.
Hepatology (Baltimore, Md.)|April 1, 1994
Cyclosporine withdrawal for nephrotoxicity in liver transplant recipients does not result in sustained improvement in kidney function and causes cellular and ductopenic rejectionW J Sandborn, J E Hay, M K Porayko, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
The American Journal of Gastroenterology|August 1, 1993
Prevalence of peritonitis and the ascitic fluid protein concentration among chronic liver disease patientsD B Hurwich, K D Lindor, J E Hay, et al.
Hepatology (Baltimore, Md.)|August 1, 1991
The metabolic bone disease of primary sclerosing cholangitisJ E Hay, K D Lindor, R H Wiesner, et al.
Journal of Clinical Microbiology|January 1, 1996
Clinical comparison of isolator, Septi-Chek, nonvented tryptic soy broth, and direct agar plating combined with thioglycolate broth for diagnosing spontaneous bacterial peritonitisJ E Hay, F R Cockerill, D Kaese, et al.
Transplantation Proceedings|February 1, 1991
Bone disease in liver transplant recipients: incidence, timing, and risk factorsM K Porayko, R H Wiesner, J E Hay, et al.
Transplantation|November 15, 1994
Treatment of early cellular rejection following liver transplantation with intravenous methylprednisolone. The effect of dose on responseR H Wiesner, J Ludwig, R A Krom, et al.
The American Journal of Gastroenterology|September 1, 1994
Etiology and incidence of unconjugated hyperbilirubinemia after orthotopic liver transplantationL K Gates, R H Wiesner, R A Krom, et al.
Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 1, 1996
Liver transplantation for primary sclerosing cholangitis: impact of risk factors on outcomeR H Wiesner, M K Porayko, J E Hay, et al.
Transplantation Proceedings|April 1, 1993
Early cellular rejection treated with high-dose intravenous corticosteroid therapy is associated with a decrease in the incidence of steroid-resistant rejection and graft failure from rejectionR H Wiesner, M K Porayko, H E Wahlstrom, et al.
Transplantation Proceedings|June 1, 1996
Bone loss after orthotopic liver transplantation: FK 506 versus cyclosporineK M Park, J E Hay, S G Lee, et al.
Hepatology (Baltimore, Md.)|April 1, 1994
Cyclosporine withdrawal for nephrotoxicity in liver transplant recipients does not result in sustained improvement in kidney function and causes cellular and ductopenic rejectionW J Sandborn, J E Hay, M K Porayko, et al.
Pageof 5